559 related articles for article (PubMed ID: 25305695)
21. Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature.
Soukup V; Babjuk M; Bellmunt J; Dalbagni G; Giannarini G; Hakenberg OW; Herr H; Lechevallier E; Ribal MJ
Eur Urol; 2012 Aug; 62(2):290-302. PubMed ID: 22609313
[TBL] [Abstract][Full Text] [Related]
22. Cytologic and cystoscopic predictors of recurrence and progression in patients with low-grade urothelial carcinoma.
Jackson J; Barkan GA; Kapur U; Wojcik EM
Cancer Cytopathol; 2013 Jul; 121(7):398-402. PubMed ID: 23364860
[TBL] [Abstract][Full Text] [Related]
23. Urothelial cancer of bladder in young versus older adults: clinical and pathological characteristics and outcomes.
Telli O; Sarici H; Ozgur BC; Doluoglu OG; Sunay MM; Bozkurt S; Eroglu M
Kaohsiung J Med Sci; 2014 Sep; 30(9):466-70. PubMed ID: 25224770
[TBL] [Abstract][Full Text] [Related]
24. Transurethral Resection of the Bladder Tumour as a Treatment Method in Children with Transitional Cell Carcinoma of the Bladder--Analysis of Our Material and Literature Review.
Apoznański W; Rysiakiewicz J; Polok M; Rysiakiewicz K; Siekanowicz P; Hilger T; Zagierski J; Hilger M; Nowak I; Kolęda P; Szydełko T
Adv Clin Exp Med; 2015; 24(3):505-9. PubMed ID: 26467141
[TBL] [Abstract][Full Text] [Related]
25. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
26. Management and follow-up of urothelial neoplasms of the bladder in children: a report from the TREP project.
Di Carlo D; Ferrari A; Perruccio K; D'Angelo P; Fagnani AM; Cecchetto G; Bisogno G
Pediatr Blood Cancer; 2015 Jun; 62(6):1000-3. PubMed ID: 25545665
[TBL] [Abstract][Full Text] [Related]
27. Management of low grade papillary bladder tumors.
Herr HW; Donat SM; Reuter VE
J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
[TBL] [Abstract][Full Text] [Related]
28. Can patient selection for bladder preservation be based on response to chemotherapy?
Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
[TBL] [Abstract][Full Text] [Related]
29. Behavior of urothelial carcinoma with respect to anatomical location.
Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
[TBL] [Abstract][Full Text] [Related]
30. The Association of A Number of Predictive Factors for The Recurrence of Papillary Urothelial Neoplasm of Low Malignant Potential: Prognostic Analysis From Multiple Academic Centers.
Kim KH; Lee SH; Kim SI; Chung BH; Koo KC; Cho JS; Bang WJ; Park JY; Hong SJ
Urol J; 2019 Dec; 16(6):558-562. PubMed ID: 30882164
[TBL] [Abstract][Full Text] [Related]
31. Nonmuscular Invasive Urothelial Carcinoma of the Bladder in Pediatric and Young Adult Patients: Age-related Outcomes.
Caione P; Patruno G; Pagliarulo V; Bulotta AL; Salerno A; Diomedi Camassei F; Lastilla G; Gerocarni Nappo S
Urology; 2017 Jan; 99():215-220. PubMed ID: 27450943
[TBL] [Abstract][Full Text] [Related]
32. Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.
Smaldone MC; Jacobs BL; Smaldone AM; Hrebinko RL
Urology; 2008 Sep; 72(3):613-6. PubMed ID: 18554696
[TBL] [Abstract][Full Text] [Related]
33. Narrow-band imaging (NBI) and white light (WLI) transurethral resection of the bladder in the treatment of non-muscle-invasive bladder cancer.
Montanari E; de la Rosette J; Longo F; Del Nero A; Laguna P
Arch Ital Urol Androl; 2012 Dec; 84(4):179-83. PubMed ID: 23427740
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of transitional cell carcinoma of the bladder in childhood.
Bujons A; Caffaratti J; Garat JM; Villavicencio H
J Pediatr Urol; 2014 Feb; 10(1):167-70. PubMed ID: 24035638
[TBL] [Abstract][Full Text] [Related]
35. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.
Hu Z; Mudaliar K; Quek ML; Paner GP; Barkan GA
Ann Diagn Pathol; 2014 Apr; 18(2):49-52. PubMed ID: 24370460
[TBL] [Abstract][Full Text] [Related]
36. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.
Kryvenko ON; Epstein JI
J Urol; 2013 Jun; 189(6):2083-6. PubMed ID: 23228381
[TBL] [Abstract][Full Text] [Related]
37. Bladder urothelial cell carcinoma as a rare cause of haematuria in children: Our experience and review of current literature.
ElSharnoby O; Fraser N; Williams A; Scriven S; Shenoy M
J Pediatr Surg; 2022 Jul; 57(7):1409-1413. PubMed ID: 34563358
[TBL] [Abstract][Full Text] [Related]
38. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
[TBL] [Abstract][Full Text] [Related]
39. Bladder cancer in Sri Lanka: experience from a tertiary referral center.
Goonewardena SA; De Silva WA; De Silva MV
Int J Urol; 2004 Nov; 11(11):969-72. PubMed ID: 15509199
[TBL] [Abstract][Full Text] [Related]
40. Frequent FGFR3 mutations in urothelial papilloma.
van Rhijn BW; Montironi R; Zwarthoff EC; Jöbsis AC; van der Kwast TH
J Pathol; 2002 Oct; 198(2):245-51. PubMed ID: 12237885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
